The “develOpment of metabolic and functional markers of Dementia IN Older people” (ODINO) Study: Rationale, Design and Methods

The “develOpment of metabolic and functional markers of Dementia IN Older people” (ODINO) Study: Rationale, Design and Methods

Mild cognitive impairment (MCI), also termed mild neurocognitive disorder, includes a heterogeneous group of conditions characterized by declines in one or more cognitive domains greater than that expected during “normal” aging but not severe enough to impair functional abilities. MCI has been assoc...

Full description

Bibliographic Details
Main Authors: Anna Picca, Daniela Ronconi, Hélio J. Coelho-Junior, Riccardo Calvani, Federico Marini, Alessandra Biancolillo, Jacopo Gervasoni, Aniello Primiano, Cristina Pais, Eleonora Meloni, Domenico Fusco, Maria Rita Lo Monaco, Roberto Bernabei, Maria Camilla Cipriani, Emanuele Marzetti, Rosa Liperoti
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Personalized Medicine
Subjects:
aging
biomarkers
cytokines
cognitive decline
Alzheimer’s disease
metabolomics
Online Access:https://www.mdpi.com/2075-4426/10/2/22

Internet

https://www.mdpi.com/2075-4426/10/2/22

Similar Items